K
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SCHEDULE 13G/A17.3 KBKalVista Pharmaceuticals, Inc.Aug 14, 4:51 PM ET·0001231919-26-000933
- SCHEDULE 13G/A13.7 KBKalVista Pharmaceuticals, Inc.Aug 14, 4:15 PM ET·0001214659-26-010418
- SCHEDULE 13G/A8.5 KBKalVista Pharmaceuticals, Inc.Aug 14, 12:48 PM ET·0001104659-26-096807
- SCHEDULE 13G8.4 KBKalVista Pharmaceuticals, Inc.Aug 11, 10:42 AM ET·0001104659-26-093853
- 8-K381.4 KBKalVista Pharmaceuticals, Inc.Jun 11, 4:44 PM ET·0001140361-26-024949
- 10-Q6.6 MBKalVista Pharmaceuticals, Inc.May 14, 4:05 PM ET·0001193125-26-223976
- 8-K1.1 MBKalVista Pharmaceuticals, Inc.Apr 29, 8:30 AM ET·0001140361-26-017656
- 8-K189.6 KBKalVista Pharmaceuticals, Inc.Mar 25, 7:16 AM ET·0001193125-26-122784
- 8-K2.5 MBKalVista Pharmaceuticals, Inc.Jan 8, 4:47 PM ET·0001193125-26-007801
- 10-Q8.3 MBKalVista Pharmaceuticals, Inc.Nov 10, 11:45 AM ET·0001193125-25-274442
Insiders
10Tickers
No tickers on record
Addresses
business
200 CROSSING BOULEVARD
FRAMINGHAM, MA, 01702
mailing
200 CROSSING BOULEVARD
FRAMINGHAM, MA, 01702
Former Names
- Carbylan Therapeutics, Inc.2016-11-21
- Carbylan Biosurgery, Inc2013-01-03
- Carbylan Biosurgery Inc2005-12-29